Imugene Limited Company

Imugene is a clinical stage immuno-oncology company developing a range of new treatments that seek to activate the immune system of cancer patients to identify and eradicate tumors.
Industry: Genomic and Epigenominc Instabillity
Headquarters: Australia
Visit Website
nede@imugene.com
Register and Claim Ownership